CoChat

In vivo nanoparticle imaging of innate immune cells can serve as a marker of disease severity in a model of multiple sclerosis

Open access
Kirschbaum, Klara, Sonner, Jana K., Zeller, Matthias W., Deumelandt, Katrin, Bode, Julia, Sharma, Rakesh, Krüwel, Thomas, Fischer, Manuel, Hoffmann, Angelika, Costa da Silva, Milene, Muckenthaler, Martina U., Wick, Wolfgang, Tews, Björn, Chen, John W., Heiland, Sabine, Bendszus, Martin, Platten, Michael, Breckwoldt, Michael O. · 2016 · Proceedings of the National Academy of Sciences
Cited by 103

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Significance: Multiple sclerosis is a devastating neurological condition that can affect the entire central nervous system. Innate immune cells mediate the underlying tissue damage, but visualizing these cellular culprits is currently not possible. Diagnosis and treatment monitoring are performed by MRI, but so far imaging markers are unspecific and based on secondary parameters (edema/gliosis; blood–brain barrier disruption). We used a nanoparticle-based approach to image brain-resident and infiltrating innate immune cells in inflammatory lesions. Nanoparticle uptake is specific for innate immune cells and correlates with clinical severity. Thus, targeting innate immunity by molecular imaging may serve as a direct marker of disease activity with the potential of clinical translation to a wide variety of inflammatory conditions for improved diagnosis and treatment monitoring.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1609397113

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 103

Metadata

Authors
Kirschbaum, K., Sonner, J. K., Zeller, M. W., Deumelandt, K., Bode, J., Sharma, R., Krüwel, T., Fischer, M., Hoffmann, A., Costa da Silva, M., Muckenthaler, M. U., Wick, W., Tews, B., Chen, J. W., Heiland, S., Bendszus, M., Platten, M., & Breckwoldt, M. O.
Venue
Proceedings of the National Academy of Sciences
Published
2016-10-31
Volume
113
Issue
46
Pages
13227-13232
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2540248011
Cited by
103
References
12
FWCI
10.68
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In vivo nanoparticle imaging of innate immune cells can serve as a marker of disease severity in a model of multiple sclerosis. https://app.cochat.ai/papers/10.1073/pnas.1609397113
The paper
Kirschbaum, K., Sonner, J. K., Zeller, M. W., Deumelandt, K., Bode, J., Sharma, R., Krüwel, T., Fischer, M., Hoffmann, A., Costa da Silva, M., Muckenthaler, M. U., Wick, W., Tews, B., Chen, J. W., Heiland, S., Bendszus, M., Platten, M., & Breckwoldt, M. O. (2016). In vivo nanoparticle imaging of innate immune cells can serve as a marker of disease severity in a model of multiple sclerosis. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1609397113

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.